Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.2K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

311
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
311
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

224
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
224
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

2.1K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vagal activation inhibits insulin release through neuronal nitric oxide synthase in obese male mice.

Science signaling·2026
Same author

Intestinal fructose metabolism triggers a glucagon-like peptide-1-β-cell axis to prevent post-fructose hyperglycaemia.

The Journal of physiology·2025
Same author

Voltage-gated calcium channel α<sub>2</sub>δ-1 subunit is involved in the regulation of glucose-stimulated GLP-1 secretion in mice.

American journal of physiology. Gastrointestinal and liver physiology·2025
Same author

Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides.

Nutrients·2024
Same author

Blockade of glucagon increases muscle mass and alters fiber type composition in mice deficient in proglucagon-derived peptides.

Journal of diabetes investigation·2023
Same author

A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels.

Journal of diabetes investigation·2023

Related Experiment Video

Updated: Jun 18, 2025

Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells
08:03

Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells

Published on: November 26, 2019

8.1K

Advances in basic research on glucagon and alpha cells.

Yoshitaka Hayashi1,2

  • 1Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Chikusa-Ku, Nagoya, 464-8601 Japan.

Diabetology International
|August 5, 2024
PubMed
Summary

Glucagon primarily regulates amino acid metabolism, not blood glucose. Research reveals new feedback loops and the impact of glucagon resistance in diseases like diabetes.

Keywords:
Amino acid catabolismDiabetes mellitusGLP-1GlucagonomaHyperaminoacidemia

More Related Videos

Confocal Laser Scanning Microscopy of Calcium Dynamics in Acute Mouse Pancreatic Tissue Slices
10:49

Confocal Laser Scanning Microscopy of Calcium Dynamics in Acute Mouse Pancreatic Tissue Slices

Published on: April 13, 2021

4.0K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

65.2K

Related Experiment Videos

Last Updated: Jun 18, 2025

Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells
08:03

Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells

Published on: November 26, 2019

8.1K
Confocal Laser Scanning Microscopy of Calcium Dynamics in Acute Mouse Pancreatic Tissue Slices
10:49

Confocal Laser Scanning Microscopy of Calcium Dynamics in Acute Mouse Pancreatic Tissue Slices

Published on: April 13, 2021

4.0K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

65.2K

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • Glucagon's role in plasma amino acid regulation was noted in the 1980s.
  • Recent animal studies suggest glucagon's major function is amino acid metabolism, not glucose regulation.
  • Novel feedback mechanisms between islet alpha cells and the liver involving glucagon and amino acids have been identified.

Purpose of the Study:

  • To explore the physiological role of glucagon in amino acid metabolism.
  • To investigate the link between hyperglucagonemia, glucagon resistance, and metabolic diseases.
  • To understand the mechanisms regulating islet cell proliferation by amino acids.

Main Methods:

  • Review of recent basic research using animal models of glucagon deficiency.
  • Analysis of clinical data on hyperglucagonemia in patients with diabetes and nonalcoholic fatty liver disease.
  • Examination of human genetic studies involving glucagon receptor mutations.
  • Case study analysis of liver transplantation outcomes.

Main Results:

  • Severe glucagon resistance in humans causes hyperaminoacidemia, islet alpha cell expansion, and pancreatic hypertrophy.
  • Hepatic glucagon resistance is increasingly linked to hyperglucagonemia in diabetes and fatty liver disease.
  • Liver transplantation resolving glucagon resistance normalized hyperglucagonemia and reversed pancreatic hypertrophy and metabolic disorders.

Conclusions:

  • Glucagon plays a critical role in regulating amino acid metabolism.
  • Glucagon resistance is a significant factor in the pathophysiology of metabolic diseases.
  • Further research into amino acid-mediated islet cell proliferation mechanisms is crucial for understanding glucagon-related diseases.